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INTRODUCTION 
The “powerhouse” of cells are mitochondria. In the last few 
decades, it has been highlighted that impaired mitochondrial 
function is associated with several pathological conditions, 
such as excitotoxicity, ischemia/reperfusion-, 
neurodegenerative diseases, and oxidative stress.  
Energy limiting conditions lead to dysfunction of these 
organelles through losing inner mitochondrial membrane 
impermeability and/or losing mitochondrial membrane 
potential (ΔΨm). A serious dysfunction accompanied by 
complete depolarization can lead to cytosolic ATP pool 
depletion. It is not surprising that has to be a rescue 
mechanism that is able to support to maintain the cellular 
ATP pool in those cells, where ATP synthesis through the 
oxidative phosphorylation is not satisfactory. A possible 
rescue mechanism revealed by our laboratory is the 
mitochondrial substrate-level phosphorylation catalyzed by 
succinyl-CoA ligase and other succinyl-CoA ligase 
supporting enzymes. 
Mitochondrial diseases are collectively considered to be a 
primary cause of encephalomyopathies and other 
multisystem maladies. A sizeable fraction of this pool of 
diseases are associated with mtDNA depletion. Many animal 
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models have been generated to model mtDNA depletion by 
explicitly deleting genes essential for mtDNA replication, 
although only one study has addressed the role of succinyl-
CoA ligase. 
 
OBJECTIVES 
1. Set up animal models for succinyl-CoA ligase 
deficiencies and investigate the impact of the mitochondrial 
substrate-level phosphorylation on the bioenergetics 
parameters.  
 
2. Advise the following questions: 
a. How and what extent do succinyl-CoA ligase 
mutations affect substrate-level 
phosphorylation?  
b. What happens if the SKDCC axis (alpha-
ketoglutarate dehydrogenase complex, DT-
diaphorases, complex III and cytochrome 
c), the primary, central enzyme, the succinyl-
CoA ligase itself was damaged?  
c. What would be the difference between ATP- 
or GTP-forming subunit affecting mutations?  
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3. Using this animal model, reveal and elucidate the 
details of known symptoms, alteration in metabolites and 
mtDNA content in order to contribute the better 
understanding of the succinyl-CoA ligase mutation and the 
function of the succinyl-CoA ligase enzyme.   
 
4. Reveal a potential compensatory mechanism which 
is able to prevent phenotypic alterations in the heterozygous 
patients and animal model. 
 
METHODS 
Animals 
Mice were of either 129/SvEv (Sucla2 heterozygote strain) 
or C57Bl/6N (Suclg2 heterozygote strain) background.  
Sucla2+/− heterozygous mice were generated by Texas 
A&M Institute for Genomic Medicine (TIGM) using a 
gene-trapping. 
Suclg2 heterozygote mice [B6-Suclg2Gt(pU-
21KBW)131Card] were generated at CARD, Kumamoto 
University, Japan also using a gene-trapping technique 
Neither Sucla2 −/− nor Suclg2 −/− mice were ever born 
from mating heterozygous mice, suggesting that complete 
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absence of either gene is incompatible with life in mice. 
By mating Sucla2 heterozygous mice with Suclg2 
heterozygous mice, double transgenic 
(Sucla2+/−/Suclg2+/−) mice were born and viable. 
Isolation of mitochondria 
Isolation of mitochondria from mouse liver, heart, and 
brain: liver and heart mitochondria from all animals were 
isolated with a differrential centrifugation method.  
Nonsynaptic brain mitochondria were isolated on a Percoll 
gradient. Protein concentration was determined using the 
bicinchoninic acid assay.  
Determination of protein concentration 
Protein concentration was determined using the 
bicinchoninic acid assay (ThermoFisher SCIENTIFIC - 
Pierce™ BCA Protein Assay Kit), and calibrated using 
bovine serum albumin standards using a Tecan Infinite® 
200 PRO series plate reader (Tecan Deutschland GmbH, 
Crailsheim, Germany). 
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Determination of membrane potential (ΔΨm) in 
isolated liver mitochondria 
Mitochondrial membrane potential (ΔΨm) of isolated 
mitochondria was estimated using fluorescence quenching of 
safranin O. The cationic dye can accumulate inside the 
negatively charged matrix of energized mitochondria. 
Fluorescence was recorded in either a Hitachi F-4500 
fluorescence spectrophotometer or using the O2k-
Fluorescence LED2-Module of the OROBOROS Oxygraph-
2k. To convert safranin O fluorescence into millivolts, a 
voltage-fluorescence calibration curve was constructed.  
 
Mitochondrial respiration 
Oxygen consumption was estimated polarographically 
using an Oxygraph-2k. 0.5-1 mg -depending on the tissue 
of origin- mitochondria was suspended in 2 ml incubation 
medium, the composition of which was identical to that 
for m determination. Experiments were performed at 
37 oC.  Oxygen concentration and oxygen flux 
(pmol·s−1·mg−1; negative time derivative of oxygen 
concentration, divided by mitochondrial mass per volume 
and corrected for instrumental background oxygen flux 
arising from oxygen consumption of the oxygen sensor 
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and back-diffusion into the chamber) were recorded using 
DatLab software (Oroboros Instruments). 
Cell cultures  
Fibroblast cultures from skin biopsies from the patient 
with no SUCLA2 expression and a control subject were 
prepared. Cells were grown on poly-L-ornithine coated 
flasks for 5-7 days in RPMI1640 medium supplemented 
with 10% fetal bovine serum and 2 mM glutamine and 
kept at 37 oC in 5% CO2. The medium was also 
supplemented with penicillin, streptomycin, and 
amphotericin. 
Mitochondrial membrane potential (ΔΨm) 
determination in in situ mitochondria of permeabilized 
fibroblast cells 
ΔΨm was estimated using fluorescence quenching of the 
cationic dye safranine O due to its accumulation inside 
energized mitochondria. Fibroblasts were harvested by 
trypsinization, permeabilized and suspended in a medium 
identical to that as for ΔΨm measurements in isolated 
mitochondria. Substrates were 5 mM glutamate and 5 mM 
malate. Fluorescence was recorded in a Tecan Infinite® 
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200 PRO series plate reader. Experiments were performed 
at 37 oC.  
Western blot analysis 
Isolated mitochondria were solubilized in RIPA buffer 
containing a cocktail of protease inhibitors and frozen. 
Frozen pellets were thawed on ice, their protein 
concentration was determined, loaded at a concentration 
of 3.75 µg per well on the gels and separated by sodium 
dodecyl sulfate – polyacrylamide gel electrophoresis 
(SDS-PAGE). Separated proteins were transferred to a 
methanol-activated polyvinylidene difluoride membrane. 
Immunoblotting was performed as recommended by the 
manufacturers of the antibodies. Rabbit polyclonal anti-
SUCLG1, anti-SUCLG2, anti-VDAC1 and anti-SUCLA2 
primary antibodies were used. Immunoreactivity was 
detected using the appropriate peroxidase-linked 
secondary antibody (donkey anti-rabbit) and enhanced 
chemiluminescence detection reagent. Densitometric 
analysis of the bands was performed in Fiji software.  
mtDNA content 
Total DNA was isolated from 4 pooled tissues from each 
mouse group using QIAamp DNA Mini Kit (QIAGEN) 
8 
 
following the manufacturer's instructions.  Relative 
mtDNA content was quantified in triplicate by real-time 
PCR using primers for cox1 and normalized against the 
nuclear encoded actinB gene. DNA was amplified in an 
ABI 7900 system. 
Electron transport chain complex and citrate synthase 
activity assays 
Enzymatic activities of rotenone-sensitive NADH CoQ 
reductase (complex I), succinate cytochrome c reductase 
(complex II/III), succinate dehydrogenase (complex II, 
SDH), cytochrome c oxidase (COX, complex IV) and 
citrate synthase (CS), a mitochondrial marker enzyme, 
were determined in isolated mitochondria.  
 
Determination of succinyl-CoA ligase activity 
ATP- and GTP-forming succinyl-CoA ligase activity in 
isolated mitochondria was determined at 30 °C using 
DTNB. Rates of 2-nitro-5-thiobenzoate formation were 
followed spectrophotometrically during constant stirring.  
Determination of acylcarnitines 
Multiple reaction monitoring transitions of butyl ester 
derivatives of acylcarnitines from dry blood spots and 
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stable isotope internal standards were analyzed by 
electrospray ionization-tandem mass spectrometry (MS-
MS). 
Determination of Sucla2 mRNA by qRT-PCR  
mRNA coding for Sucla2 was quantified by qPCR in two 
different laboratories using two different 'housekeeping' 
mRNAs for normalization, ß-actin or proteasome 26S 
subunit, ATPase 4 (Psmc4). In both cases, total RNA was 
isolated from the organs (livers, hearts, brains) of at least 
four mice per age group and genotype (wild type or 
Sucla2+/−) with RNeasy Micro Kit (Qiagen, Hilden, 
Germany) according to the manufacturer’s instructions. 
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RESULTS 
 
Sucla2 mRNA quantification, succinyl-CoA ligase 
subunit expression and enzymatic activities in wild 
type vs Sucla2+/− mice  
Mutant Sucla2 mice were generated using a gene-trapping 
technique.  
Total RNA was isolated from the livers, hearts and brains 
of 3-, 6-, and 12 months old wild type and Sucla2+/− mice 
(four animals per group), and Sucla2 mRNA was 
quantified by qPCR, ratioed to β-actin or Psmc4 
expression. mRNA coding for Sucla2 was significantly 
decreased (26-71%) in the tissues obtained from 
Sucla2+/− mice, compared to those obtained from wild 
type littermates. These results are in accordance to those 
obtained from immunodetection of Sucla2 subunit by 
Western blotting. As per our Western Blot results, 
Sucla2+/− mice exhibited up to 76% decrease in Sucla2 
expression, depending on the tissue and the age of the 
mice. Concomitantly, Sucla2+/− mice exhibited up to 66% 
reduction in Suclg1 protein, but also up to 177% increase 
in Suclg2 protein.  
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In agreement with the above results regarding 
Suclg1/g2/a2 subunit quantification, ATP-forming 
activity of Sucla2+/− mice decreased, while GTP-forming 
activity increased, though only in heart mitochondria, for 
all ages. 
 
Characterization of succinyl-CoA ligase subunit 
expression and enzymatic activities of wild type vs 
Suclg2+/− mice  
Suclg2+/− mice exhibited an up to 56% decrease in Suclg2 
expression, a mostly insignificant decrease in Suclg1 
expression, and no rebound increase in Sucla2 expression. 
The variability in the decrease in Suclg2 (and Sucla2) 
expression in these transgenic mouse lines probably 
reflects the 'leakiness' of the mutant allele that could 
produce wild-type mRNAs by alternative splicing around 
the gene trap cassette.  
 
Characterization of succinyl-CoA ligase subunit 
expression and enzymatic activities of 
Sucla2+/−/Suclg2+/− double heterozygote mice 
We cross-bred Sucla2+/− mice with Suclg2+/− mice, 
which yielded viable Sucla2+/−/Suclg2+/− offsprings. 
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The results of Western blotting of mitochondria isolated 
from the brains, livers, hearts of 12 months old wild type 
vs Sucla2+/−/Suclg2+/− mice probing for SUCLG1, 
SUCLG2 and SUCLA2 (and VDAC1 as loading control) 
are the following: The deletion of one Sucla2 allele still 
yields a rebound increase in Sucgl2 expression in liver, 
albeit protracted because these mice also lack one Suclg2 
allele. By the same token, the anticipated decrease (due to 
deletion of one Suclg2 allele) in Suclg2 expression is lost, 
presumably because of the effect(s) of deletion of the 
Sucla2 allele, antagonizing the diminution in expression 
of Suclg2. These results are also reflected from the 
measured ATP- and GTP-forming activities of wild type 
vs Sucla2+/−/Suclg2+/− mice: ATP-forming activity is 
diminished in the double heterozygote mice compared to 
wild type littermates due to loss of one Sucla2 allele, 
however, GTP-forming activity remains unaffected, 
despite the loss of one Suclg2 allele.  
 
The effect of deleting one Sucla2 allele on 
mitochondrial respiration  
Except for one combination for state 2 respiration and five 
combinations for state 3 respiration, the remaining 84 
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combinations of substrates per tissue of origin per age of 
mice did not reveal statistically significant differences 
between wild type and Sucla2+/− mice.  
 
The effect of deleting one Sucla2 allele on m and 
substrate-level phosphorylation during inhibition of 
complex I by rotenone or true anoxia 
We evaluated matrix substrate-level phosphorylation 
during either inhibition of complex I by rotenone or during 
anoxia. There were no differences between mitochondria 
from wild type and Sucla2+/− mice. Likewise, when 
substrate-level phosphorylation was examined during 
inhibition of the respiratory chain by rotenone instead of 
anoxia, no differences between wild type and Sucla2+/− 
mice mitochondria were observed. By the same token, no 
differences in mitochondrial respiration or substrate-level 
phosphorylation during chemical or true anoxia was 
observed by comparing Suclg2+/− versus wild type 
littermate mice. By comparing wild type vs 
Sucla2+/−/Suclg2+/− double heterozygote mice, we also 
observed no difference in the ability of substrate-level 
phosphorylation to maintain ANT in the forward mode, 
except for using glutamate + malate + β-hydroxybutyrate 
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as substrates (a substrate combination that does not favor 
substrate-level phosphorylation) in liver mitochondria, 
where we obtained the full spectrum of results, ranging 
from maintenance of substrate-level phosphorylation, to 
its abolition. However, in permeabilized fibroblasts from 
a control subject vs a patient suffering from complete 
deletion of SUCLA2, the in situ mitochondria from the 
patient are unable to perform substrate-level 
phosphorylation during respiratory inhibition by rotenone.  
 
The effect of deleting one Sucla2 allele on electron 
transport chain enzymes/citrate synthase 
We investigated the effect of deleting one Sucla2 allele in 
mice on complex I, II, II/III and IV activities, ratioed to 
citrate synthase activity. As per our results, mitochondria 
from all tissues and all ages revealed no statistically 
significant differences between wild type and Sucla2+/ 
mice. However, by comparing wild type vs 
Sucla2+/−/Suclg2+/− double heterozygote mice, there 
was a statistically significant increase in succinate 
dehydrogenase activity in heart mitochondria. 
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The effect of deleting one Sucla2 allele on mtDNA  
Because of the involvement of succinyl-CoA ligase in the 
maintenance of mtDNA, we compared the amount of 
mtDNA in the tissues of wild type vs Sucla2+/− mice. 
Relative mtDNA content from the livers, hearts and brains 
of 3-, 6- and 12 months old mice was quantitated by real 
time-PCR. There was a moderate but statistically 
significant decrease in mtDNA in all tissues of 3 months 
old mice, and in the brains of 12 months old mice. 
Furthermore, by comparing wild type vs 
Sucla2+/−/Suclg2+/− double heterozygote mice, there 
was a much greater statistically significant decrease in 
mtDNA in the livers and brains of double heterozygote 
mice, compared to wild-type littermates.  
 
The effect of deleting one Sucla2 allele on blood 
carnitine esters 
We measured the levels of 20 carnitine esters in the blood 
of mice. As per our results, there were statistically 
significant increases in 36 out of 63 comparisons of 
carnitine esters in the blood of Sucla2+/− mice from all 
age groups compared to that from wild type mice, but also 
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6 occasions in which carnitine esters of Sucla2+/− mice is 
decreased compared to those of wild type mice.  
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CONCLUSION 
 
The most important finding of this thesis is, that the 
upregulation of Suclg2 in Sucla2+/‒ mice can compensate 
the severity of the phenotype of this genetic modification. 
However, Suclg2 one-allele deletion was not accompanied 
by Sucla2 upregulation. From the experiments with 
Sucla2+/‒ mice we obtained the information that deletion of 
one Sucla2 allele is associated with a decrease in Suclg1 
expression and a rebound increase in Suclg2 expression. 
Furthermore, this is reflected in reciprocal decrease vs. 
increase in ATP-forming vs. GTP-forming succinyl-CoA 
ligase activity. However, from the experiments with 
Suclg2+/‒ mice, we concluded that deletion of one Suclg2 
allele was not associated with the rebound effects as seen in 
the Sucla2+/− mice. A plausible explanation of this finding 
is that the Suclg2 is responsible for compensatory 
mechanisms and the upregulation of the one residual Suclg2 
allele is so strong that it can compensate the loss of the 
knocked-out allele. We also could see in the experiments 
with Sucla2+/‒/Suclg2+/‒ mice that the anticipated decrease 
(due to deletion of one Suclg2 allele) in Suclg2 expression is 
lost, presumably because of the effect(s) of deletion of the 
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Sucla2 allele, antagonizing the diminution in the expression 
of Suclg2. We concluded that the effect of deleting one 
Sucla2 allele up-regulating Suclg2 expression is so dominant 
that it adequately antagonizes or even supersedes the 
effect(s) of a concomitant loss of one Suclg2 allele.  
Regarding the fact that succinyl-CoA ligase is at the 
intersection of several metabolic pathways it is surprising 
that SUCLA2 heterozygous patients are asymptomatic. 
According to our data regarding bloodspot analyses, we 
found a phenotypic alteration in heterozygous mice, namely 
in acyl-carnitine levels. These results are suggesting, that 
heterozygous patient with only one SUCLA2 mutant allele 
may also show changes in blood acyl-carnitines.  
With our study we could profile the metabolism of two 
transgenic mouse models for β-subunit components of 
succinyl-CoA ligase and highlight a compensatory 
mechanism. The fact that in those patients where SUCLA2 
or SUCLG2 mutations were found showed milder severity 
compared to those where the invariant α subunit was 
affected, also supports the notion that α subunit is responsible 
for maintaining both ATP- and GTP-forming activities. We 
further concluded from these results that the loss of the alpha 
subunit cannot be compensated by the upregulation of any 
other subunit. 
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